WallStreetZenWallStreetZen

NASDAQ: SYRE
Spyre Therapeutics Inc Stock Ownership - Who owns Spyre Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Spyre Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Scott L. BurrowsCFO2026-09-0218,232$89.35
$1.63MSell
Heidy KingjonesOfficer2026-09-02400$14.50
$5.80kBuy
Heidy KingjonesOfficer2026-09-02400$90.00
$36.00kSell
Cameron TurtleCEO2026-09-01400$89.07
$35.63kSell
Cameron TurtleCEO2026-09-013,700$88.06
$325.82kSell
Cameron TurtleCEO2026-09-018,400$87.15
$732.06kSell
Cameron TurtleCEO2026-09-012,500$86.36
$215.90kSell
Scott L. BurrowsCFO2026-09-012,016$88.03
$177.47kSell
Heidy KingjonesOfficer2026-09-014,845$86.40
$418.61kSell
Heidy KingjonesOfficer2026-09-0127,999$14.50
$405.99kBuy

1 of 10

SYRE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SYRE insiders and whales buy or sell their stock.

SYRE Shareholders

What type of owners hold Spyre Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fairmount Funds Management LLC11.66%10,283,659$946.41MInsider
Baker Bros Advisors LP3.51%3,094,590$284.80MInsider
Orbimed Advisors LLC3.21%2,829,748$260.42MInsider
Novartis Bioventures Ltd2.47%2,175,314$200.19MInsider
Anthony G. Quinn1.16%1,025,680$94.39MInsider
Cameron Turtle0.63%552,540$50.85MInsider
George Georgiou0.51%446,337$41.08MInsider
David George Lowe0.24%212,040$19.51MInsider
Armen Shanafelt0.24%207,619$19.11MInsider
Jonathan Alspaugh0.19%165,372$15.22MInsider

1 of 3

SYRE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SYRE0.11%24.47%Net SellingNet Selling
ABVX0.07%0.00%
PRAX0.12%50.28%Net SellingNet Buying
IMVT0.05%57.73%Net BuyingNet Selling
IONS0.11%3.35%Net SellingNet Selling
View Top Biotech Stocks

Spyre Therapeutics Stock Ownership FAQ

Who owns Spyre Therapeutics?

Spyre Therapeutics (NASDAQ: SYRE) is owned by 0.11% institutional shareholders, 24.47% Spyre Therapeutics insiders, and 75.42% retail investors. Fairmount Funds Management LLC is the largest individual Spyre Therapeutics shareholder, owning 10.28M shares representing 11.66% of the company. Fairmount Funds Management LLC's Spyre Therapeutics shares are currently valued at $945.79M.

If you're new to stock investing, here's how to buy Spyre Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.